NeuroVive Pharmaceutical AB Starts Investor Relations Partnership With Laika Consulting
5/8/2013 10:06:31 AM
More...
|
NeuroVive Pharmaceutical AB First Day of Trading on NASDAQ OMX Stockholm
4/10/2013 11:27:36 AM
More...
|
NeuroVive Pharmaceutical AB Admitted to Trading on NASDAQ OMX Stockholm
3/25/2013 9:44:38 AM
More...
|
NeuroVive Pharmaceutical AB Release: 600th Heart Attack Patient Recruited into Phase III CicloMulsion® CIRCUS Trial
3/22/2013 9:32:15 AM
More...
|
NeuroVive Pharmaceutical AB Appoints Anna Malm Bernsten and Boel Flodgren to Its Board of Directors
3/18/2013 9:49:11 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Collaborates With NeuroVive Pharmaceutical AB to Develop Two Innovative Cardio-Cerebral Vascular Products in China
11/20/2012 9:02:07 AM
More...
|
Selcia Limited and NeuroVive Pharmaceutical AB Announce Breakthrough in Development of Mitochondrial Energy Regulators
10/8/2012 11:33:30 AM
More...
|
NeuroVive Pharmaceutical AB and To-BBB technologies BV Awarded Eurostars Grant for Development of Stroke Therapy
9/29/2011 8:04:22 AM
More...
|
Selcia Limited and NeuroVive Pharmaceutical AB to Develop New Mitochondrial Medicines for Chronic and Acute Diseases
9/19/2011 9:29:11 AM
More...
|
NeuroVive Pharmaceutical AB Obtains U.S. Orphan Drug Designation for Traumatic Brain Injury
12/6/2010 9:06:57 AM
More...
|
|